Jan David Wald
Jan Wald has over 35 years of experience with Medical Device and Technology companies, most recently as a Managing Director at Med World Advisors tasked with managing all sell side engagements and previous to that at Ornim Medical as Vice President Corporate Development, where he also had responsibility for the Clinical, Regulatory and Quality Departments. Prior to Ornim he was a Sell-Side Medical Technology Analyst focusing on cardiology, orthopedics, oncology, and neurology and was intimately involved in providing institutional research and due diligence for capital markets activity. Prior to working as an analyst, he held management positions at Guidant Corporation and Honeywell Inc. in Clinical Sciences and Research and Development. He was responsible at Guidant for developing the software and algorithms for the first implantable dual chamber defibrillator as well as overseeing the group responsible for developing the clinical protocols, conducting the trials and analyzing the data for its defibrillator programs within its Cardiac Rhythm Management Business Area. At Honeywell, he managed programs focused on developing image processing, robotic and machine learning algorithms several of which were transferred to Honeywell product divisions. He did Post-Doctoral studies at the University of Minnesota at the Center for Human Learning, has a Ph.D. from Brandeis University and an MBA from the University of St. Thomas.